Baltimore opted out of Maryland’s opioid settlement. Now it’s getting $45 million.

Baltimore has reached a $45 million settlement with pharmaceutical company Allergan related to the city’s lawsuit tied to the opioid epidemic. It’s a big sum compared to what the city would have received had it joined Maryland in a similar agreement. City leaders took a gamble in 2023 when they became the only jurisdiction in the state to opt out of Maryland’s settlement with drug companies in hopes of securing a larger payout.